Soligenix (SNGX) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

SNGX is expected to report earnings to rise 15.38% to -150 cents per share on May 12

Q1'23

Est.

$-1.50

Q4'22

Missed

by $0.17

Q3'22

Beat

by $0.02

Q2'22

Beat

by $0.02

Q1'22

Missed

by $0.03

The last earnings report on March 28 showed earnings per share of -129 cents, missing the estimate of -112 cents. With 23.45K shares outstanding, the current market capitalization sits at 8.57M.

View a ticker or compare two or three

Compare

SNGX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For SNGX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a manufacturer of biodefense vaccines and oral therapeutic products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

29 Emmons Drive

Phone

+1 609 538-8200

Employees

Web

https://www.soligenix.com